Zimmer gets pediatric clearance for spinal fixation system

Zimmer Holdings ($ZMH) has received an additional clearance for its proprietary Universal Clamp spinal fixation system. The system, which is used in conjunction with spinal fusion surgeries, is now indicated for treatment of idiopathic and neuromuscular scoliosis in patients 8 years of age or older--a first for the U.S., the company says. Zimmer release

Suggested Articles

The drug that treats atrial fibrillation, flecainide, has been around since the '80s. Grace Colón, CEO of InCarda, thinks it needs a face-lift.

3M, maker of the ubiquitous Littmann stethoscope brand, has teamed up with Eko to create a new digital version that amplifies sounds and adds AI.

Study data from Medtronic showed more patients reported improvements in their chronic back pain after treatments with the devicemaker’s tiny implant.